hyaluronate
RxNorm concept 62372, ingredient (in).
- RxCUI
- 62372
- Term type
- Ingredient (IN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/62372 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- Viscoat (BN, has tradename)
- Hyalgan (BN, has tradename)
- Amvisc (BN, has tradename)
- Healon (BN, has tradename)
- Biolon (BN, has tradename)
- Provisc (BN, has tradename)
- Healon5 (BN, has tradename)
- Supartz (BN, has tradename)
- Orthovisc (BN, has tradename)
- Euflexxa (BN, has tradename)
- Bionect (BN, has tradename)
- DisCoVisc (BN, has tradename)
- Gel-One (BN, has tradename)
- IPM Wound (BN, has tradename)
- Monovisc (BN, has tradename)
- Genvisc (BN, has tradename)
- Gel-Syn (BN, has tradename)
- Visco-3 (BN, has tradename)
- Trivisc (BN, has tradename)
- Durolane (BN, has tradename)
- Hymovis (BN, has tradename)
- Triluron (BN, has tradename)
- sodium hyaluronate 10 MG/ML (SCDC, ingredient of)
- sodium hyaluronate 16 MG/ML (SCDC, ingredient of)
- sodium hyaluronate 23 MG/ML (SCDC, ingredient of)
- hyaluronate Topical Cream (SCDF, ingredient of)
- hyaluronate Ophthalmic Solution (SCDF, ingredient of)
- hyaluronate Topical Gel (SCDF, ingredient of)
- ascorbic acid / hyaluronate Oral Capsule (SCDF, ingredient of)
- hyaluronate Prefilled Syringe (SCDF, ingredient of)
- chondroitin sulfates / hyaluronate Prefilled Syringe (SCDF, ingredient of)
- glucosamine / hyaluronate / methylsulfonylmethane Oral Tablet (SCDF, ingredient of)
- sodium hyaluronate 30 MG/ML (SCDC, ingredient of)
- sodium hyaluronate 0.002 MG/MG (SCDC, ingredient of)
- sodium hyaluronate 12 MG/ML (SCDC, ingredient of)
- sodium hyaluronate 15 MG/ML (SCDC, ingredient of)
- chondroitin sulfates / hyaluronate Injectable Product (SCDG, ingredient of)
- ascorbic acid / hyaluronate Oral Product (SCDG, ingredient of)
- ascorbic acid / hyaluronate Pill (SCDG, ingredient of)
- hyaluronate Injectable Product (SCDG, ingredient of)
- hyaluronate Ophthalmic Product (SCDG, ingredient of)
- hyaluronate Oral Product (SCDG, ingredient of)
- hyaluronate Topical Product (SCDG, ingredient of)
- glucosamine / hyaluronate / methylsulfonylmethane Oral Product (SCDG, ingredient of)
- glucosamine / hyaluronate / methylsulfonylmethane Pill (SCDG, ingredient of)
- sodium hyaluronate 0.025 MG/MG (SCDC, ingredient of)
- sodium hyaluronate 17 MG/ML (SCDC, ingredient of)
- sodium hyaluronate 2 MG/ML (SCDC, ingredient of)
- sodium hyaluronate 20 MG/ML (SCDC, ingredient of)
- hyaluronic acid 20 MG (SCDC, ingredient of)
- hyaluronic acid 1 MG (SCDC, ingredient of)
- chondroitin sulfates / glucosamine / hyaluronate / methylsulfonylmethane Oral Product (SCDG, ingredient of)
- chondroitin sulfates / glucosamine / hyaluronate / methylsulfonylmethane Pill (SCDG, ingredient of)
- chondroitin sulfates / glucosamine / hyaluronate / methylsulfonylmethane Oral Tablet (SCDF, ingredient of)
- sodium hyaluronate 22 MG/ML (SCDC, ingredient of)
- hyaluronate Topical Foam (SCDF, ingredient of)
- sodium hyaluronate 8.4 MG/ML (SCDC, ingredient of)
- hyaluronate Injection (SCDF, ingredient of)
- hyaluronic acid 8 MG/ML (SCDC, ingredient of)
- hyaluronic acid 1.1 MG (SCDC, ingredient of)
And 14 more in the API response.
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 62372 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/62372 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 62372. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.